Conformational analysis and theoretical quantitative size and shape-affinity relationships of N4-protonated N1-arylpiperazine 5-HT1A serotoninergic ligands

Journal of Molecular Structure: THEOCHEM

Volumn 397, Issue 1-3, 1997, Pages 129-145

  Cocchi, M ^a   Fanelli, F ^a   Menziani, M C ^a   De Benedetti, P G ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

5 HT1A; Arylpiperazines; Conformational analysis; QSAR; Size shape descriptors

Indexed keywords

EID: 0008852355     PISSN: 01661280     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-1280(96)04990-1     Document Type: Article

References (29)

1. I. van Wijngaarden, M. Th. M. Tulp, W. Soudijn, Eur. J. Pharmacol. 188 (1990) 301.
2. R.A. Glennon, Drug Dev. Res. 26 (1992) 251.
3. G.D.H. Dijkstra, Reel. Trav. Chim. Pays-Bas 112 (1993) 151.
4. W. Kuipers, I. van Wijngaarden, C.G. Kruse, M. ter H. van Amstel, M. Th. M. Tulp, A.P. Ijzerman, J. Med. Chem. 38 (1995) 1942.
5. B.Y. Ho, A. Karschin, T. Branchek, N. Davidson, H.A. Lester, FEBS 312 (1992) 259.
6. H. Weinstein, D. Chou, S. Kang, C.L. Johnson, J.P. Green, Int. J. Quant. Chem. (Quant. Biol. Symp.) 3 (1976) 135.
7. P.G. De Benedetti, M. Cocchi, M.C. Menziani, F. Fanelli, J. Mol. Struct. (Theochem) 280 (1993) 283.
8. P.G. De Benedetti, M. Cocchi, M.C. Menziani, F. Fanelli, J. Mol. Struct. (Theochem) 305 (1994) 101.
9. M. Cocchi, M.C. Menziani, F. Fanelli, P.G. De Benedetti, J. Mol. Struct. (Theochem) 331 (1995) 79.
10. P.G. De Benedetti, M.C. Menziani, M. Cocchi, F. Fanelli, J. Mol. Struct. (Theochem) 333 (1995) 1.
11. M.J.S. Dewar, E.G. Zoebisch, E.F. Healey, J.J.P. Stewart, J. Am. Chem. Soc. 107 (1985) 3902.
12. MOPAC version 6.0, QCPE 455.
13. AMSOL version 5.0, QCPE 606.
14. A. Karlsson, C. Petterson, S. Sundell, L.E. Arvidsson, U. Hacksell, Acta Chem. Scand. B 42 (1988) 231.
15. S. Kang, C.L. Johnson, J.P. Green, J. Mol. Struct. 15 (1973) 453.
16. QUANTA/CHARMM, Molecular Simulations Inc., 16 New England Executive Park, Burlington, MA 01803-5297, USA, 1995.
17. A. Cartier, J.L. Rivail, Chemometrics and Intelligent Laboratory Systems 1 (1987) 335.
18. C.J. Cramer, D.G. Truhlar, Science 256 (1992) 213.
19. D.J. Giesen, C.J. Cramer, D.G. Truhlar, J. Phys. Chem. 99 (1995) 7137.
20. S.E. Hillver, L. Björk, Y.L. Li et al., J. Med. Chem. 33 (1990) 1541.
21. R.W. Baker, C. Chothia, P. Pauling, Mol. Pharmacol. 9 (1973) 23.
22. Z. Chilmonczyk, A. Les, A. Wozniakowska, J. Cyubulski, A.E. Koziol, M. Gadniec, J. Med. Chem. 38 (1995) 1701.
23. A.J. Sleight, S.J. Peroutka, Naunyn-Schemiedeberg's Arch. Pharmacol. 343 (1991) 109.
24. M. Hibert, P. Moser, Drugs of the Future 15 (1990) 159.
25. R.A. Glennon, N.A. Naiman, M.E. Pierson, J.D. Smith, A.M. Ismaiel, M. Titeler, R.A. Lyon, J. Med. Chem. 32 (1989) 1921.
26. B.J. van Steen, I. van Wijngaarden, M.Th.M. Tulp, W. Soudijn, J. Med. Chem. 36 (1993) 2751.
27. R.A. Glennon, N.A. Naiman, R.A. Lyon, M. Titeler, J. Med. Chem. 31 (1988) 1968.
28. E.W. Taylor, S.S. Nikam, G. Lambert, A.R. Martin, D.L. Nelson, Mol. Pharmacol. 34 (1988) 42.
29. I.A. Cliffe, A. Fletcher, Drugs of the Future 18(7) (1993) 631.